Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin
Clinical trial NCT00966914 · COMPLETED
Trial details
- NCT number
- NCT00966914
- Sponsor
- BioNumerik Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2013-04-01
- Enrollment
- 540
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.